Showing results (31-40 of 55) with videos related to
Sort By:
Pageof 6
Ebiomedicine|May 14, 2024
Human antibody signatures towards the Chlamydia trachomatis major outer membrane protein after natural infection and vaccinationIda Rosenkrands, Anja W Olsen, Sara Knudsen, et al.Plos One|October 27, 2015
Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular AntibodiesAlexander Badamchi-Zadeh, Paul F McKay, Martin J Holland, et al.Infection and Immunity|October 24, 2003
PPE protein (Rv3873) from DNA segment RD1 of Mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE familyLimei Meng Okkels, Inger Brock, Frank Follmann, et al.Frontiers in Microbiology|February 26, 2019
Genital Infiltrations of CD4<sup>+</sup> and CD8<sup>+</sup> T Lymphocytes, IgA<sup>+</sup> and IgG<sup>+</sup> Plasma Cells and Intra-Mucosal Lymphoid Follicles Associate With Protection Against Genital <i>Chlamydia</i> <i>trachomatis</i> Infection in Minipigs Intramuscularly Immunized With UV-Inactivated Bacteria Adjuvanted With CAF01Karin Erneholm, Emma Lorenzen, Sarah Bøje, et al.Journal of Pharmaceutical Sciences|February 17, 2018
Unusual Self-Assembly of the Recombinant Chlamydia trachomatis Major Outer Membrane Protein-Based Fusion Antigen CTH522 Into Protein NanoparticlesFabrice Rose, Kasper Karlsen, Pernille Rønde Jensen, et al.Microbes and Infection|February 13, 2017
Intrauterine inoculation of minipigs with Chlamydia trachomatis during diestrus establishes a longer lasting infection compared to vaginal inoculation during estrusEmma Lorenzen, Frank Follmann, Jan O Secher, et al.Biomaterials|June 25, 2021
Chitin-derived polymer deacetylation regulates mitochondrial reactive oxygen species dependent cGAS-STING and NLRP3 inflammasome activationJoanna L Turley, Hannah B T Moran, Craig P McEntee, et al.Frontiers in Immunology|May 21, 2016
A Multi-Component Prime-Boost Vaccination Regimen with a Consensus MOMP Antigen Enhances Chlamydia trachomatis ClearanceAlexander Badamchi-Zadeh, Paul F McKay, Bette T Korber, et al.Plos One|September 9, 2008
Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirementsElse Marie Agger, Ida Rosenkrands, Jon Hansen, et al.Vaccine|November 16, 2019
Type I IFN signalling is required for cationic adjuvant formulation (CAF)01-induced cellular immunity and mucosal primingCraig P McEntee, Hannah B T Moran, Natalia Muñoz-Wolf, et al.Pageof 6